NCT01772563View on ClinicalTrials.gov

Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 4, 2013

Primary Completion Date

May 30, 2014

Study Completion Date

April 22, 2021

Conditions
Neoplasms
Interventions
DRUG

volasertib

Solution for infusion

DRUG

itraconazole

capsules

Trial Locations (2)

1077

PRA Hungary Ltd., Phase I. Clinical Pharmacology Unit, Budapest

1122

National Institute of Oncology, Budapest

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY